{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:35:11Z","timestamp":1791232511104,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054464","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T17:44:45Z","timestamp":1359049485000},"page":"e54464","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Arginase Treatment Prevents the Recovery of Canine Lymphoma and Osteosarcoma Cells Resistant to the Toxic Effects of Prolonged Arginine Deprivation"],"prefix":"10.1371","volume":"8","author":[{"given":"James W.","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milcah C.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"R\u00fctgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime F.","family":"Modiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Cvetkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Tepic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semcancer.2005.04.002","article-title":"Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells","volume":"15","author":"DN Wheatley","year":"2005","journal-title":"Seminars in cancer biology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/excr.1999.4779","article-title":"Single amino acid (arginine) deprivation induces G1 arrest associated with inhibition of cdk4 expression in cultured human diploid fibroblasts","volume":"255","author":"J Lamb","year":"2000","journal-title":"Experimental cell research"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","article-title":"Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis","volume":"24","author":"TL Lam","year":"2011","journal-title":"Pigment cell & melanoma research"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1054\/bjoc.2000.1353","article-title":"Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells","volume":"83","author":"L Scott","year":"2000","journal-title":"British journal of cancer"},{"key":"ref5","article-title":"A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma","author":"T Yau","year":"2012","journal-title":"Investigational new drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","article-title":"Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies","volume":"22","author":"F Izzo","year":"2004","journal-title":"Journal of clinical oncology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/jn\/108.12.1944","article-title":"Arginine: an essential amino acid for the cat","volume":"108","author":"JG Morris","year":"1978","journal-title":"The Journal of nutrition"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jn\/115.4.524","article-title":"Nutritional and metabolic responses to arginine deficiency in carnivores","volume":"115","author":"JG Morris","year":"1985","journal-title":"The Journal of nutrition"},{"key":"ref9","first-page":"439","article-title":"Breed-specific Canine Lymphoproliferative Diseases","volume":"44","author":"JF Modiano","year":"2006","journal-title":"Cold Spring Harb Mon"},{"key":"ref10","first-page":"1","article-title":"The occurrence of tumors in domestic animals","author":"WA Priester","year":"1980","journal-title":"National Cancer Institute monograph"},{"key":"ref11","first-page":"307","article-title":"Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County","volume":"40","author":"CR Dorn","year":"1968","journal-title":"Journal of the National Cancer Institute"},{"key":"ref12","first-page":"909","article-title":"A prospective survey of familial canine lymphosarcoma","volume":"72","author":"DE Onions","year":"1984","journal-title":"Journal of the National Cancer Institute"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/01652176.1994.9694435","article-title":"Clustering in canine malignant lymphoma","volume":"16","author":"E Teske","year":"1994","journal-title":"The Veterinary quarterly"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1939-1676.2002.tb02411.x","article-title":"Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma","volume":"16","author":"LD Garrett","year":"2002","journal-title":"Journal of veterinary internal medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1158\/0008-5472.CAN-04-4613","article-title":"Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk","volume":"65","author":"JF Modiano","year":"2005","journal-title":"Cancer research"},{"key":"ref16","first-page":"31","article-title":"Naturally occurring translational models for development of cancer gene therapy","volume":"10A","author":"JF Modiano","year":"2006","journal-title":"Gene Ther Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygeno.2007.05.001","article-title":"Heritability and segregation analysis of osteosarcoma in the Scottish deerhound","volume":"90","author":"JC Phillips","year":"2007","journal-title":"Genomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1090-0233(98)80059-2","article-title":"Host related risk factors for canine osteosarcoma","volume":"156","author":"G Ru","year":"1998","journal-title":"Veterinary journal"},{"key":"ref19","first-page":"159","article-title":"Comparative aspects of osteosarcoma. Dog versus man","author":"SJ Withrow","year":"1991","journal-title":"Clinical orthopaedics and related research"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1292\/jvms.58.469","article-title":"Establishment and characterization of a new canine B-cell leukemia cell line","volume":"58","author":"M Nakaichi","year":"1996","journal-title":"The Journal of veterinary medical science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.leukres.2010.01.021","article-title":"Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma","volume":"34","author":"BC Rutgen","year":"2010","journal-title":"Leukemia research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00205629","article-title":"Canine lymphoma-associated antigens defined by murine monoclonal antibodies","volume":"24","author":"Z Steplewski","year":"1987","journal-title":"Cancer immunology, immunotherapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-2427(97)00053-6","article-title":"Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma","volume":"59","author":"Y Momoi","year":"1997","journal-title":"Veterinary immunology and immunopathology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.leukres.2007.04.003","article-title":"A novel canine lymphoma cell line: a translational and comparative model for lymphoma research","volume":"31","author":"WC Kisseberth","year":"2007","journal-title":"Leukemia research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bone.2011.05.008","article-title":"Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach","volume":"49","author":"MC Scott","year":"2011","journal-title":"Bone"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF03033696","article-title":"Arginine catabolism, liver extracts and cancer","volume":"8","author":"DN Wheatley","year":"2002","journal-title":"Pathology oncology research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-5-17","article-title":"Deprivation of arginine by recombinant human arginase in prostate cancer cells","volume":"5","author":"EC Hsueh","year":"2012","journal-title":"Journal of hematology & oncology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1042\/CBI20100451","article-title":"Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes","volume":"34","author":"YP Bobak","year":"2010","journal-title":"Cell biology international"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.bjc.6601134","article-title":"Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells","volume":"89","author":"DN Wheatley","year":"2003","journal-title":"British journal of cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjc.6600681","article-title":"Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures","volume":"88","author":"R Philip","year":"2003","journal-title":"British journal of cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.25489","article-title":"L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase","volume":"117","author":"R Pieters","year":"2011","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08880018.2010.484852","article-title":"Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma","volume":"28","author":"C Jorck","year":"2011","journal-title":"Pediatric hematology and oncology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL","volume":"28","author":"HJ Muller","year":"1998","journal-title":"Critical reviews in oncology\/hematology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MPH.0b013e3181e6f003","article-title":"Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia","volume":"32","author":"EA Raetz","year":"2010","journal-title":"Journal of pediatric hematology\/oncology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","article-title":"Pegylated arginase I: a potential therapeutic approach in T-ALL","volume":"115","author":"CP Hernandez","year":"2010","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T17:44:20Z","timestamp":1562607860000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054464"}},"subtitle":[],"editor":[{"given":"Kristy L.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054464","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}